ArticleScientific reports2025
The serum evaluation of sex hormones including DHEAs, DHT, testosterone in oral lichen planus patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychoneurobiological Aspects of Burning Mouth Syndrome and Oral Lichen Planus: A Narrative Review.Medicina (Kaunas, Lithuania) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lichen planus (LP), an inflammatory and chronic disorder, is immune-mediated and influences nails, skin, hair, and mucosal tissues. Autoimmune diseases affect females more commonly, and it is reported that there is an association between certain sex hormones and autoimmune diseases. This study aims to evaluate the serum levels of DHT, Dehydroepiandrosterone (DHEAs), and testosterone (T) in patients who have oral lichen planus (OLP) compared to healthy people. Forty female patients diagnosed with OLP were selected. They were considered to have the same mean age as 40 patients in the control group. The enzyme-linked immunosorbent assay investigated Androgens' serum levels (Monobomal kit, Sherkat Azmayeshgah Bartar). The age mean 51.90 ± 11.52 for the patient group and 49.10 ± 11.63 for the control group. Erosive LP was the most common subtype of LP, 72.5% of LP lesions. The differences between DHEAs (p value = 0.126), DHT (p value = 0.710), and T's serum level (p value = 0.376) groups were not significant. There was no difference between hormonal levels during menopause and the non-menopause group. There was no correlation between OLP and androgens. DHEAs, DHT, and T levels were not different between case and control groups; therefore, the results did not support any neuroendocrine etiology for OLP. Also, there was no change in these androgens' serum levels during the transition from pre-menopause to post-menopause.Trial registration: The study adhered to the ethical principles of the Helsinki Declaration (2002 version) and received approval from the ethics committee of Shiraz University of Medical Sciences, Shiraz, Iran (IR.SUMS.REC.1397.709).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.